17 December 2024 in Infection Ecology & Epidemiology
This article investigates the escalating occurrence of zoonotic diseases in Africa, attributing their spread to climate change and human activities. Africa’s unique combination of biodiversity, reliance on animal husbandry, and swift urbanization heightens its susceptibility. Climate change disrupts ecosystems and animal habitats, intensifying human-wildlife interactions. Urbanization, inadequate sanitation, and insufficient healthcare infrastructure further facilitate disease spread. Climate-induced displacement adds another layer of complexity. Mitigation strategies include improving surveillance systems, fostering early detection via point-of-care diagnostics and digital contact tracing, and investing in vaccines and therapeutics. Our purpose of this is to advocate for sustainable land use, robust community-level public health systems, international cooperation, and resource-sharing. We also emphasize the need for effective vector-control policies, dedicated research funding, and annual awareness, vaccination, and early detection campaigns in endemic regions.
25 January 2025 in Evidence Public Health
Nucleic acid therapeutics are emerging as transformative agents in antiviral treatment, leveraging precise genetic interventions to combat viral infections. This mini-review examines key modalities including Antisense Oligonucleotides (ASOs), Small Interfering RNAs (siRNAs), CRISPR-based gene editing, and mRNA vaccines. These approaches utilize cellular mechanisms to inhibit viral replication and offer targeted gene silencing, crucial for addressing rapidly mutating viruses. The review highlights advancements in delivery systems, particularly lipid nanoparticles, and discusses the clinical potential and challenges of these therapies, such as safety concerns related to immune responses and genotoxicity. It also underscores the rapid development and effectiveness of mRNA vaccines demonstrated during the COVID-19 pandemic, reflecting the adaptability and potential of nucleic acid therapies. The review calls for continued innovation and multidisciplinary research to enhance the efficacy, safety, and clinical application of these promising antiviral strategies.